PLPL Stock Overview
Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Plandaí Biotechnology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0007 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -99.00% |
| 1 Year Change | -99.80% |
| 3 Year Change | -99.83% |
| 5 Year Change | -99.80% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PLPL | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -99.0% | -8.0% | -2.5% |
| 1Y | -99.8% | -17.5% | -0.04% |
Return vs Industry: PLPL underperformed the US Biotechs industry which returned -12.8% over the past year.
Return vs Market: PLPL underperformed the US Market which returned 4.7% over the past year.
Price Volatility
| PLPL volatility | |
|---|---|
| PLPL Average Weekly Movement | 7,328.4% |
| Biotechs Industry Average Movement | 11.2% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 4.0% |
Stable Share Price: PLPL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PLPL's weekly volatility has increased from 3976% to 7328% over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Roger Baylis-Duffield | www.plandaibiotech.com |
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa.
Plandaí Biotechnology, Inc. Fundamentals Summary
| PLPL fundamental statistics | |
|---|---|
| Market cap | US$8.89k |
| Earnings (TTM) | -US$4.32m |
| Revenue (TTM) | US$338.48k |
0.0x
P/S Ratio0.0x
P/E RatioIs PLPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLPL income statement (TTM) | |
|---|---|
| Revenue | US$338.48k |
| Cost of Revenue | US$907.48k |
| Gross Profit | -US$568.99k |
| Other Expenses | US$3.75m |
| Earnings | -US$4.32m |
Last Reported Earnings
Sep 30, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PLPL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/11 14:48 |
| End of Day Share Price | 2025/04/09 00:00 |
| Earnings | 2016/09/30 |
| Annual Earnings | 2016/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Plandaí Biotechnology, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.